Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Chadi Saifan, Mark Samarneh, Norbert Shtaynberg, Rabih Nasr, Elie El-Charabaty & Suzanne El-Sayegh. (2013) Treatment of confirmed B12 deficiency in hemodialysis patients improves Epogen® requirements. International Journal of Nephrology and Renovascular Disease 6, pages 89-93.
Read now
Read now
Gere Sunder-Plassmann, Wolfgang C Winkelmayer & Manuela Födinger. (2000) Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease. Expert Opinion on Investigational Drugs 9:11, pages 2637-2652.
Read now
Read now
L. Moelby, G. Nielsen, K. Rasmussen, M. K. Jensen & K. O. Pedersen. (1997) Metabolic cobalamin deficiency in patients with low to low-normal plasma cobalamins. Scandinavian Journal of Clinical and Laboratory Investigation 57:3, pages 209-215.
Read now
Read now
Articles from other publishers (10)
Stefanie Kather, Niels Grützner, Peter H. Kook, Franziska Dengler & Romy M. Heilmann. (2019) Review of cobalamin status and disorders of cobalamin metabolism in dogs. Journal of Veterinary Internal Medicine 34:1, pages 13-28.
Crossref
Crossref
Ralph Green. (2008)
Indicators for Assessing Folate and Vitamin B
12
Status and for Monitoring the Efficacy of Intervention Strategies
. Food and Nutrition Bulletin 29:2_suppl1, pages S52-S63.
Crossref
Crossref
Manuela Födinger, Mario Veitl, Sonja Skoupy, Jadwiga Wojcik, Claudia Röhrer, Wolfgang Hagen, Heidi Puttinger, Anna-Christine Hauser, Andreas Vychytil & Gere Sunder-Plassmann. (2003) Effect of TCN2 776C>G on vitamin B12 cellular availability in end-stage renal disease patients. Kidney International 64:3, pages 1095-1100.
Crossref
Crossref
Anne-Mette Hvas, Jørgen Ellegaard & Ebba Nexø. (2001) Vitamin B12 Treatment Normalizes Metabolic Markers But Has Limited Clinical Effect: A Randomized Placebo-controlled Study. Clinical Chemistry 47:8, pages 1396-1404.
Crossref
Crossref
Bjørn J Bolann, Jan Dag Solli, Jörn Schneede, Kjell A Grøttum, Arne Loraas, Morgan Stokkeland, Asbjørn Stallemo, Arne Schjøth, Rolf Bruun Bie, Helga Refsum & Per Magne Ueland. (2000) Evaluation of Indicators of Cobalamin Deficiency Defined as Cobalamin-induced Reduction in Increased Serum Methylmalonic Acid. Clinical Chemistry 46:11, pages 1744-1750.
Crossref
Crossref
M. Faurschou, O.J. Nielsen, M.K. Jensen & H.C. Hasselbalch. (2000) High prevalence of hyperhomocysteinemia due to marginal deficiency of cobalamin or folate in chronic myeloproliferative disorders. American Journal of Hematology 65:2, pages 136-140.
Crossref
Crossref
Lars Moelby, Karsten Rasmussen, Troels Ring & Gert Nielsen. (2000) Relationship between methylmalonic acid and cobalamin in uremia. Kidney International 57:1, pages 265-273.
Crossref
Crossref
Anders Lindgren, Birgitta Swolin, Ola Nilsson, Kurt W. Johansson & Anders F. Kilander. (1997) Serum methylmalonic acid and total homocysteine in patients with suspected cobalamin deficiency: A clinical study based on gastrointestinal histopathological findings. American Journal of Hematology 56:4, pages 230-238.
Crossref
Crossref
H.J. Naurath, E. Joosten, R. Riezler, S. Stabler, R.H. Allen & J. Lindenbaum. (1995) Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations. The Lancet 346:8967, pages 85-89.
Crossref
Crossref
E Joosten, A van den Berg, R Riezler, HJ Naurath, J Lindenbaum, SP Stabler & RH Allen. (1993) Metabolic evidence that deficiencies of vitamin B−12 (cobalamin), folate, and vitamin B−6 occur commonly in elderly people. The American Journal of Clinical Nutrition 58:4, pages 468-476.
Crossref
Crossref